Analyst Ratings for Sanofi (SNY)
SNY Rating Summary
SNY Price Target Summary
- Highest: $120.00 (Jefferies)
- Lowest: $50.00 (BNP Paribas Exane)
- Average: $66.70
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$66.70 (+57.4%)
* Over Last 12-Mos
Rating Score: 2.3 / 10
Percentile Rank: 18%
Avg. $ Target:
$66.70 (+57.4%)
* Over Last 12-Mos
Rating Score: 2.3 / 10
Percentile Rank: 18%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/1/2026 | Morgan Stanley | Sarita Kapila | Downgrade | Equalweight (Overweight) |
52.00 (55.00) |
46.58 (42.38) |
-9.02% | Details |
| 4/20/2026 | BNP Paribas Exane | Peter Verdult | Downgrade | Neutral (Outperform) |
50.00 (N/A) |
47.72 (42.38) |
-11.19% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
